Correlation Between Neurocrine Biosciences and Reviva Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Neurocrine Biosciences and Reviva Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neurocrine Biosciences and Reviva Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Neurocrine Biosciences and Reviva Pharmaceuticals Holdings, you can compare the effects of market volatilities on Neurocrine Biosciences and Reviva Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neurocrine Biosciences with a short position of Reviva Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neurocrine Biosciences and Reviva Pharmaceuticals.

Diversification Opportunities for Neurocrine Biosciences and Reviva Pharmaceuticals

0.54

Correlation Coefficient

Neurocrine Biosciences  Reviva Pharmaceuticals

Very weak diversification

The 3 months correlation between Neurocrine and Reviva is 0.54. Overlapping area represents the amount of risk that can be diversified away by holding Neurocrine Biosciences and Reviva Pharmaceuticals Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Reviva Pharmaceuticals and Neurocrine Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neurocrine Biosciences are associated (or correlated) with Reviva Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Reviva Pharmaceuticals has no effect on the direction of Neurocrine Biosciences i.e., Neurocrine Biosciences and Reviva Pharmaceuticals go up and down completely randomly.

Pair Corralation between Neurocrine Biosciences and Reviva Pharmaceuticals

Given the investment horizon of 90 days Neurocrine Biosciences is expected to generate 49.0 times less return on investment than Reviva Pharmaceuticals. But when comparing it to its historical volatility, Neurocrine Biosciences is 12.9 times less risky than Reviva Pharmaceuticals. It trades about 0.04 of its potential returns per unit of risk. Reviva Pharmaceuticals Holdings is currently generating about 0.16 of returns per unit of risk over similar time horizon. If you would invest  13.00  in Reviva Pharmaceuticals Holdings on September 17, 2024 and sell it today you would earn a total of  18.00  from holding Reviva Pharmaceuticals Holdings or generate 138.46% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Neurocrine Biosciences  vs.  Reviva Pharmaceuticals Holding

Neurocrine Biosciences

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Neurocrine Biosciences are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of fairly strong forward indicators, Neurocrine Biosciences is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.

Reviva Pharmaceuticals

Risk-Adjusted Performance

12 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Reviva Pharmaceuticals Holdings are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain technical indicators, Reviva Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Neurocrine Biosciences and Reviva Pharmaceuticals

The main advantage of trading using opposite Neurocrine Biosciences and Reviva Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neurocrine Biosciences position performs unexpectedly, Reviva Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Reviva Pharmaceuticals will offset losses from the drop in Reviva Pharmaceuticals' long position.

The idea behind Neurocrine Biosciences and Reviva Pharmaceuticals Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.